The use of NSAIDs as a first line treatment for axial spondyloarthritis is supported in a recent Cochrane review. The review of 39 studies including 4356 people found high quality evidence that both traditional and COX-2 NSAIDs were more efﬁcacious than placebo in people with axSpA. The review by the musculoskeletal group found moderate quality evidence that harms in ...
Evidence supports NSAIDs in axSpA
22 Jul 2015